Skip to content Skip to footer
Riabni: Benefits, Reviews, Info, Side Effects!
Rx Details
Riabni
Obinutuzumab, Gazyva
Riabni is the brand name for the drug rituximab.
Prescription
Monoclonal
Drugs
Biologic
rituximab biosimilar, treats certain types of cancer, treats rheumatoid arthritis, treats granulomatosis with polyangiitis, treats microscopic polyangiitis, targets CD20 protein on B cells, helps reduce inflammation, helps slow disease progression
Chills, Cough, Diarrhea, Fatigue, Fever, Headache, Infections, Infusion-Related Reactions, Itching, Joint Pain, Low Blood Cell Counts, Muscle Spasms, Nausea, Rash, Throat Irritation
Riabni is a biosimilar to Rituxan (rituximab), which is used to treat certain types of cancer and autoimmune diseases. The dosage of Riabni, like Rituxan, can vary depending on the specific condition being treated, the patient’s body surface area, and other individual factors. For example, in the treatment of non-Hodgkin’s lymphoma, the typical dosage might be 375 mg/m² administered as an intravenous infusion. For rheumatoid arthritis, the dosage might be different, often starting with two 1000 mg infusions separated by two weeks, and then repeated every 24 weeks or based on clinical evaluation. It’s important to note that the exact dosage and administration schedule should be determined by a healthcare professional based on the specific needs and condition of the patient. Always consult with a healthcare provider for accurate dosing information.
Riabni is commonly used to treat non-hodgkin’s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis.
Riabni has a favorable safety profile.
No Interactions Reported
$1,000 – $1,500
$1,000 – $2,000

A Synopsis of

Riabni

Riabni is a medication that belongs to a class of drugs known as monoclonal antibodies. It is used to treat certain autoimmune diseases such as rheumatoid arthritis, granulomatosis with polyangiitis, and microscopic polyangiitis. Riabni works by targeting specific proteins in the body that are involved in the inflammatory response, helping to reduce inflammation and alleviate symptoms associated with these conditions.

As a medical professional, I recommend Riabni to patients who have not responded well to other treatments or who are experiencing severe symptoms that impact their quality of life. It is important to follow the dosing instructions provided by your healthcare provider and to attend regular check-ups to monitor your response to the medication.

Like all medications, Riabni may cause side effects in some individuals. These can include infusion reactions, infections, and changes in blood cell counts. It is important to report any unusual symptoms or side effects to your healthcare provider promptly.

Before starting Riabni, it is important to discuss your medical history and any other medications or supplements you are taking with your healthcare provider. They can help determine if Riabni is the right treatment option for you and monitor for any potential interactions.

Overall, Riabni can be an effective treatment option for individuals with autoimmune diseases, helping to reduce inflammation and improve quality of life. If you have any questions or concerns about Riabni, do not hesitate to reach out to your healthcare provider for more information.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN